Gwendolyn Lynch, M.D.
| Appointed: |
2007 |
| Gender: |
Female |
| Languages: |
English |
Cerebrovascular Center
Biographical Sketch
Gwendolyn Lynch, MD, is a Staff Physician at Cleveland Clinic and is board-certified in neurology and vascular neurology/stroke.
As an attending physician in the neuro-intensive care unit, she is responsible for the management of patients with critical vascular disease as well as other neurocritical illnesses. She also provides care for individuals with chronic neurologic conditions, including but not limited to stroke, seizures, and neuropathy, on an outpatient basis at the Clinic's Wooster campus.
Dr. Lynch's research interests include stroke epidemiology and risk-factor modification, neurocritical care and neurocritical care quality measures.
Education & Fellowships
| Medical School: | The Ohio State University College of Medicine and Public Health, Columbus, OH |
|
| Internship: | The Ohio State University Hospitals, Internal Medicine, Columbus, OH |
| Residency: | Yale-New Haven Hospital, Neurology, New Haven, CT |
| Residency: | The Ohio State University Hospitals, Neurology, Columbus, OH |
| Fellowship: | University of Virginia Health Sciences Center, Neurocritical Care, VA |
| Fellowship: | University of Virginia Health Sciences Center, Stroke-Neurology, VA |
Certifications
Vascular Neurology
Neurology
Specialty Interests
Neurocritical care, stroke, neurocritical care quality measures, stroke epidemiology and risk factor modification, neurologic intensive care, neurosurgical intensive care.
Professional Memberships
- American Stroke Association/American Heart Association
- American Academy of Neurology
- Neurocritical Care Society
- Society of Critical Care Medicine
Specializes in Diseases and Conditions
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 10/24/2008 the review process regarding Dr. Lynch’s disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
